Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 18, 2021
SCYNEXIS has entered into a licensing agreement and strategic partnership with Hansoh Pharmaceutical Group.
read more
Wednesday, February 17, 2021
Recipharm, has extended its manufacturing license to include immunology products.
read more
Wednesday, February 17, 2021
Samsung Biologics announced IND clearance from the FDA for its client to begin clinical trials on a cancer immunotherapy.
read more
Tuesday, February 16, 2021
LipoMedix announced its lead compound, Promitil (PL-MLP), will be manufactured in the United States by ForDoz Pharma.
read more
Friday, February 12, 2021
AzurRx BioPharma has entered into an agreement with PPD for its trial evaluating micronized niclosamide for COVID-19-associated GI infections.
read more
Friday, February 12, 2021
Aerami has announced the signing of an exclusive license and development agreement with Hangzhou Chance to develop and commercialize Aerami’s drug device combination product candidate (AER-901).
read more
Friday, February 12, 2021
BrainStorm recently concluded a Type C meeting with the FDA to review aspects of the company's planned manufacturing modifications to support the development of a semi-automated commercial manufacturing process for NurOwn.
read more
Thursday, February 11, 2021
Quotient Sciences has acquired Arcinova, a U.K.-based multiservice CDMO.
read more
Wednesday, February 10, 2021
Catalent hadssigned an agreement with Trizell GmbH, to support the manufacturing of Trizell’s Phase 1 cell therapy for the treatment of micro- and macroangiopathies.
read more
Wednesday, February 10, 2021
Avacta and Mologic have entered into a commercial partnership to accelerate to market Avacta’s AffiDX SARS-CoV-2 lateral flow rapid antigen test.
read more
Tuesday, February 09, 2021
WuXi STA has agreed to purchase Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland.
read more
Tuesday, February 09, 2021
Catalent has signed an agreement to provide Decibel Therapeutics with process and analytical development, and CGMP clinical manufacturing services, for Decibel’s lead investigational gene therapy product candidate, DB-OTO.
read more
Monday, February 08, 2021
Avid Bioservices and Humanigen have entered into a manufacturing services agreement to expand production capacity for lenzilumab, Humanigen’s therapeutic candidate in development for COVID-19.
read more
Wednesday, February 03, 2021
Novartis has signed an initial agreement to leverage its manufacturing capacity and capabilities in order to address the COVID-19 pandemic by supporting the production of the Pfizer-BioNTech COVID-19 Vaccine.
read more
Monday, February 01, 2021
RedHill Biopharma announced a manufacturing agreement with Cosmo Pharmaceuticals to further expand manufacturing capacity for opaganib.
read more